|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2004-1-21
|
|
pubmed:abstractText |
To evaluate, according to the histologic type and initial stage, the mean cost (MC) of managing patients with lung cancer and the costs of the different management phases. A Markov approach was used to model these costs, based on the management of a representative nation-wide sample of 428 patients with newly diagnosed lung cancer. The 18-month MC ranged from US$ 20 691 (95% CI: 5777-50 380 for diffuse non-small-cell lung cancer (NSCLC) to US$ 31 833 (95% CI: 15 866-64 455) for localised small-cell lung cancer (SCLC); first-line treatment costs ranged from 33.8% of MC for medically inoperable localised NSCLC to 74.6% for diffuse SCLC; second- or third-line treatment costs ranged from 7.8% of MC for surgically treated localised NSCLC to 32% for locally advanced NSCLC; and the cost of palliative care ranged from 9.1% of MC for locally advanced NSCLC to 39.9% for medically inoperable localised NSCLC. The cost of first-line chemotherapy and the percentage of actively treated patients impacted more on MC than did the cost of second- or third-line chemotherapy regimens or the cost of palliative care. In conclusion, this model provides a robust economic analysis of the cost of lung cancer management, and will be useful for assessing the economic consequences of future changes in patient management.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/14735183-10146879,
http://linkedlifedata.com/resource/pubmed/commentcorrection/14735183-10360660,
http://linkedlifedata.com/resource/pubmed/commentcorrection/14735183-10389998,
http://linkedlifedata.com/resource/pubmed/commentcorrection/14735183-10470428,
http://linkedlifedata.com/resource/pubmed/commentcorrection/14735183-10841143,
http://linkedlifedata.com/resource/pubmed/commentcorrection/14735183-10920127,
http://linkedlifedata.com/resource/pubmed/commentcorrection/14735183-11230476,
http://linkedlifedata.com/resource/pubmed/commentcorrection/14735183-11336462,
http://linkedlifedata.com/resource/pubmed/commentcorrection/14735183-11384091,
http://linkedlifedata.com/resource/pubmed/commentcorrection/14735183-11562518,
http://linkedlifedata.com/resource/pubmed/commentcorrection/14735183-2113784,
http://linkedlifedata.com/resource/pubmed/commentcorrection/14735183-2166142,
http://linkedlifedata.com/resource/pubmed/commentcorrection/14735183-2845011,
http://linkedlifedata.com/resource/pubmed/commentcorrection/14735183-7577481,
http://linkedlifedata.com/resource/pubmed/commentcorrection/14735183-9294466,
http://linkedlifedata.com/resource/pubmed/commentcorrection/14735183-9552046,
http://linkedlifedata.com/resource/pubmed/commentcorrection/14735183-9704720,
http://linkedlifedata.com/resource/pubmed/commentcorrection/14735183-9850036
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0007-0920
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
26
|
|
pubmed:volume |
90
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
397-402
|
|
pubmed:dateRevised |
2009-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:14735183-Aged,
pubmed-meshheading:14735183-Aged, 80 and over,
pubmed-meshheading:14735183-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:14735183-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:14735183-Carcinoma, Small Cell,
pubmed-meshheading:14735183-Costs and Cost Analysis,
pubmed-meshheading:14735183-Female,
pubmed-meshheading:14735183-France,
pubmed-meshheading:14735183-Health Care Costs,
pubmed-meshheading:14735183-Health Care Surveys,
pubmed-meshheading:14735183-Humans,
pubmed-meshheading:14735183-Lung Neoplasms,
pubmed-meshheading:14735183-Male,
pubmed-meshheading:14735183-Markov Chains,
pubmed-meshheading:14735183-Middle Aged,
pubmed-meshheading:14735183-Models, Economic,
pubmed-meshheading:14735183-Palliative Care
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Economics of the clinical management of lung cancer in France: an analysis using a Markov model.
|
|
pubmed:affiliation |
Service de Pneumologie, Hôpital St Antoine, 184 rue du Fbg St Antoine, Paris Cedex 12 75571, France. christos.chouaid@sat.ap-hop-paris.fr
|
|
pubmed:publicationType |
Journal Article
|
